Early research (Phase 1)Study completedNCT00291889
What this trial is testing
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.
Who this might be right for
Tuberculosis (TB)
GlaxoSmithKline 50